首页> 美国政府科技报告 >Chemokine Blockade in Combination with Cytoreductive Conditioning in Metastatic Breast Cancer
【24h】

Chemokine Blockade in Combination with Cytoreductive Conditioning in Metastatic Breast Cancer

机译:趋化因子阻断联合细胞减灭术治疗转移性乳腺癌

获取原文

摘要

Chemokines have been shown to provide angiogenic effects. Blocking chemokines can reduce metastatic breast cancer cell growth. We proposed that cytoreductive conditioning will force the tumor to rely on angiogenesis as a survival mechanism and thus make the tumor more susceptible to chemokine blockade. We demonstrate that tumor cells increase production of IL-8 and MCP-1 transcripts in vivo in response to IL-8 neutralization and/or gamma irradiation and cytoxan administration. We have also demonstrated that IL-8 but not MCP-1 can function as autocrine growth or survival factor for MDA-231 cells in vitro but neutralization requires high concentrations of antibody. This observation is consistent with the more significant anti-tumor effect observed with anti-IL- 8 as a single agent and suggest that IL-8 promotes tumor cell growth through multiple mechanisms. We also showed that administration of anti-IL-8 and anti- MCP-1 can inhibit the formation of human breast cancer lung metastasis in a xenograft model.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号